Loading stock data…
Loading stock data…
US$1.09
Get one email when BFRI crosses your level. Checked every 15 minutes during market hours.
▼ -0.02 (-1.80%)down today
USD · data via Finnhub · delayed/cached up to 1–5 min
Get an AI-written, balanced deep-dive — performance, valuation, technicals, and the bull vs. bear case. Sign in to get started.
RSI (14-day)
53.4
NeutralAbove 70 can signal overbought; below 30, oversold.
MACD
0.04
Bearish momentumMACD below its signal line (0.04).
50-day average
0.98
Price aboveShort-term trend reference.
200-day average
0.93
Price aboveLong-term trend reference.
Daily values · indicators are descriptive, not trading advice
Healthcare · Drug Manufacturers - Specialty & Generic
Biofrontera Inc. is a specialty pharmaceutical company focused on the development and commercialization of dermatological products. Its primary aim is to address unmet needs in the treatment of skin diseases, with a particular emphasis on dermatology, represented by its flagship product, Ameluz. This prescription medication is used in photodynamic therapy to treat actinic keratosis and basal cell carcinoma, offering a non-invasive option for patients. Biofrontera Inc. also owns a range of other …
www.biofrontera-us.com2 strong buy · 5 buy · 1 hold · 0 sell · 0 strong sell (8 analysts, 2026-07-01)
2 strong buy · 5 buy · 1 hold · 0 sell · 0 strong sell (8 analysts, 2026-06-01)
2 strong buy · 5 buy · 1 hold · 0 sell · 0 strong sell (8 analysts, 2026-05-01)
2 strong buy · 5 buy · 1 hold · 0 sell · 0 strong sell (8 analysts, 2026-04-01)
| Quarter | Estimate | Actual | Result |
|---|---|---|---|
| 2026-07-10 | 1.49 | 1.56 | ✓ Beat |
| 2026-05-14 | -0.05 | -0.41 | ✗ Miss |
| 2026-03-19 | 0.1 | 0.5 | ✓ Beat |
| 2026-01-23 | 1.61 | 1.87 | ✓ Beat |
| 2025-11-12 | -0.56 | -0.57 | ✗ Miss |
| 2025-09-14 | 0.03 | -0.02 | ✗ Miss |
| 2025-08-13 | -0.39 | -0.57 | ✗ Miss |
Companies in the same industry, via Finnhub